Selected research
Industry Research
Microneedle Flu Vaccine Industry Research Report 2026
Market perspective
The global Microneedle Flu Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Microneedle Flu Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Microneedle Flu Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Microneedle Flu Vaccine include Sanofi, NanoPass Technologies, Microdermics and OraSure Technologies, GC Pharma, FluGen, Debiotech, CosMED Pharmaceuticals, Corium International and Becton Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Microneedle Flu Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microneedle Flu Vaccine Market by Company
Sanofi
NanoPass Technologies
Microdermics and OraSure Technologies
GC Pharma
FluGen
Debiotech
CosMED Pharmaceuticals
Corium International
Becton Dickinson and Company
Microneedle Flu Vaccine Segment by Type
Hollow Microneedle
Coated Microneedle
Solid Microneedle
Dissolving Microneedle
Microneedle Flu Vaccine Segment by Application
Influenza A
Influenza B
Microneedle Flu Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microneedle Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Microneedle Flu Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Microneedle Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hollow Microneedle
- Coated Microneedle
- Solid Microneedle
- Dissolving Microneedle
Applications
- Influenza A
- Influenza B
Companies covered
- Sanofi
- NanoPass Technologies
- Microdermics and OraSure Technologies
- GC Pharma
- FluGen
- Debiotech
- CosMED Pharmaceuticals
- Corium International
- Becton Dickinson and Company
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Microneedle Flu Vaccine Market Size (2021-2032)
- 2.2.2 Global Microneedle Flu Vaccine Sales (2021-2032)
- 2.2.3 Global Microneedle Flu Vaccine Market Average Price (2021-2032)
- 2.3 Microneedle Flu Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hollow Microneedle
- 2.3.3 Coated Microneedle
- 2.3.4 Solid Microneedle
- 2.3.5 Dissolving Microneedle
- 2.4 Microneedle Flu Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Influenza A
- 2.4.3 Influenza B
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Microneedle Flu Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Microneedle Flu Vaccine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Microneedle Flu Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Microneedle Flu Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Microneedle Flu Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Microneedle Flu Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Microneedle Flu Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Microneedle Flu Vaccine, Established Date
- 3.9 Global Microneedle Flu Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 NanoPass Technologies
- 4.2.1 NanoPass Technologies Company Information
- 4.2.2 NanoPass Technologies Business Overview
- 4.2.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
- 4.2.5 NanoPass Technologies Recent Developments
- 4.3 Microdermics and OraSure Technologies
- 4.3.1 Microdermics and OraSure Technologies Company Information
- 4.3.2 Microdermics and OraSure Technologies Business Overview
- 4.3.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
- 4.3.5 Microdermics and OraSure Technologies Recent Developments
- 4.4 GC Pharma
- 4.4.1 GC Pharma Company Information
- 4.4.2 GC Pharma Business Overview
- 4.4.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
- 4.4.5 GC Pharma Recent Developments
- 4.5 FluGen
- 4.5.1 FluGen Company Information
- 4.5.2 FluGen Business Overview
- 4.5.3 FluGen Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 FluGen Microneedle Flu Vaccine Product Portfolio
- 4.5.5 FluGen Recent Developments
- 4.6 Debiotech
- 4.6.1 Debiotech Company Information
- 4.6.2 Debiotech Business Overview
- 4.6.3 Debiotech Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Debiotech Microneedle Flu Vaccine Product Portfolio
- 4.6.5 Debiotech Recent Developments
- 4.7 CosMED Pharmaceuticals
- 4.7.1 CosMED Pharmaceuticals Company Information
- 4.7.2 CosMED Pharmaceuticals Business Overview
- 4.7.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
- 4.7.5 CosMED Pharmaceuticals Recent Developments
- 4.8 Corium International
- 4.8.1 Corium International Company Information
- 4.8.2 Corium International Business Overview
- 4.8.3 Corium International Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Corium International Microneedle Flu Vaccine Product Portfolio
- 4.8.5 Corium International Recent Developments
- 4.9 Becton Dickinson and Company
- 4.9.1 Becton Dickinson and Company Company Information
- 4.9.2 Becton Dickinson and Company Business Overview
- 4.9.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
- 4.9.5 Becton Dickinson and Company Recent Developments
5 Global Microneedle Flu Vaccine Market Scenario by Region
- 5.1 Global Microneedle Flu Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Microneedle Flu Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Microneedle Flu Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Microneedle Flu Vaccine Sales by Region: 2027-2032
- 5.3 Global Microneedle Flu Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Microneedle Flu Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Microneedle Flu Vaccine Revenue by Region: 2027-2032
- 5.4 North America Microneedle Flu Vaccine Market Facts & Figures by Country
- 5.4.1 North America Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Microneedle Flu Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Microneedle Flu Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Microneedle Flu Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Microneedle Flu Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Microneedle Flu Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Microneedle Flu Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Microneedle Flu Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Microneedle Flu Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Microneedle Flu Vaccine Market Facts & Figures by Country
- 5.7.1 South America Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Microneedle Flu Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Microneedle Flu Vaccine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Microneedle Flu Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Microneedle Flu Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Microneedle Flu Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Microneedle Flu Vaccine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Microneedle Flu Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Microneedle Flu Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Microneedle Flu Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Microneedle Flu Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Microneedle Flu Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Microneedle Flu Vaccine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Microneedle Flu Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Microneedle Flu Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Microneedle Flu Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Microneedle Flu Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Microneedle Flu Vaccine Value Chain Analysis
- 8.1.1 Microneedle Flu Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Microneedle Flu Vaccine Production Mode & Process
- 8.2 Microneedle Flu Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Microneedle Flu Vaccine Distributors
- 8.2.3 Microneedle Flu Vaccine Customers
9 Global Microneedle Flu Vaccine Analyzing Market Dynamics
- 9.1 Microneedle Flu Vaccine Industry Trends
- 9.2 Microneedle Flu Vaccine Industry Drivers
- 9.3 Microneedle Flu Vaccine Industry Opportunities and Challenges
- 9.4 Microneedle Flu Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst